Cochrane · systematic review · CD012762
Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease
Pal, S, Dixit, R, Moe, S, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library
Cystic Fibrosis and Genetic DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
3
No studies
4
Included studies
NR
No studies 4 · 57.1%Ungraded 0 · 0%Very low 3 · 42.9%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: children and young adults with SCD
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain relief (percentage relief compared to baseline) | no estimate extracted | NR | No studies |
Pain intensity (visual analogue score from 0 to 10 where 10 is the most severe pain) | no estimate extracted | 1 study · 22 participants | Very low Downgraded: risk of bias, imprecision |
Frequency of pain episodes | no estimate extracted | NR | No studies |
Change in consumption of analgesics (number of participants requiring analgesia) | no estimate extracted | 1 study · 22 participants | Very low Downgraded: risk of bias, imprecision |
Change in QoL | no estimate extracted | NR | No studies |
Change in ability to cope with ADL | no estimate extracted | NR | No studies |
Adverse effects | no estimate extracted | 1 study · 22 participants | Very low Downgraded: risk of bias, imprecision |